<DOC>
	<DOCNO>NCT00642837</DOCNO>
	<brief_summary>The objective observational study ass improvement quality life patient administer Tramadol 37.5mg/Acetaminophen 325mg tablet 10~14 week accord investigator 's discretion clinical practice .</brief_summary>
	<brief_title>A Study Health - Related Quality Life Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets</brief_title>
	<detailed_description>Recently concern Health-Related Quality Life ( HRQOL ) increase especially chronic disease . Rheumatic disease chronic disease , result functional disability impair HRQOL . Because chronic pain , patient rheumatic disease low score HRQOL general population . A several study indicate Ultracet add-on treatment nonsteroidal antiinflammatory drug ( NSAIDs ) osteoarthritis ( OA ) pain , fibromyalgia pain chronic low back pain significantly improve HRQOL , compare placebo . We use KEQ-5D ( Korean version EQ-5D health relate quality life questionnaire ) ass HRQOL . The KEQ-5D show effectively sensitive several rheumatic condition . The study hypothesis quality life improve Tramadol 37.5mg/Acetaminophen 325mg tablet administration outpatient need Tramadol 37.5mg/Acetaminophen 325mg tablet administration investigator 's discretion . This multicenter , open-label , prospective , observational study compare HRQOL use Korean version EQ-5D treatment Tramadol 37.5mg/Acetaminophen 325mg tablet assess correlation among measurement . Observational Study - No investigational drug administer</detailed_description>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Patients rheumatism moderatetosevere pain Patients administer Ultracet tramadol last one month Patients sign consent form indicate understand purpose procedure require study ( For minor 12 20 year old , patient ' legally acceptable representative ' signature also require . ) Patients experienced failure tramadol therapy discontinue Tramadol adverse event Patients impaired physical function disease may cause drug absorption anomaly , excess storage metabolic elimination disorder Patients meet prohibition tramadol acetaminophen Hypersensitive active ingredient study drug Addicted drug act central nervous system include alcohol , hypnotic , centrally act analgesic , opiates psychotropics , serious respiratory depression ( study drug may cause mild respiratory depression ) Patients head injury brain lesion risk decrease meantal awareness Patients take MAO inhibitor discontinue 2 week ago Patients peptic ulcer severe hematological anomaly Patients severe hepatic impairment , renal impairment cardiac dysfunction Patients aspirininduced asthma ( asthmatic attack induce nonsteroidal antiinflammatory drug ) Patients epilepsy control drug Patients pregnant childbearing potential study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Health-Related Quality Life</keyword>
	<keyword>KEQ-5D</keyword>
	<keyword>Sleep disturbance</keyword>
	<keyword>Sleep quality</keyword>
	<keyword>SF-1</keyword>
	<keyword>Pain intensity</keyword>
	<keyword>Pain relief</keyword>
	<keyword>Tramadol</keyword>
	<keyword>Acetaminophen</keyword>
</DOC>